Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

"Spot-On" Flea & Tick Products Alleged to Cause Serious Harm to Dogs and Cats

Pet Pharmaceutical Industry Under Fire in Multiple New Jersey Class Actions

OVER 75,000 COMPLAINTS REPORTED TO EPA ASPCA CONNECTION


News provided by

Green & Associates, LLC

Dec 08, 2011, 04:29 ET

Share this article

Share toX

Share this article

Share toX

NEWARK, N.J., Dec. 8, 2011 /PRNewswire/ -- Yet another class action was filed this week in federal court in Newark, New Jersey, in the District of New Jersey, against a manufacturer of "Spot-On" Flea and Tick products, neurotoxin pesticides placed directly on the skin of millions of household dogs and cats across the United States.

There is a growing sense of moral outrage and alarming statistics from consumers and pet advocates alike after over 75,000 complaints about the products have been reported to the EPA and nothing has been done to change the advertising, marketing or labeling of the products to alert pet owners of the possible serious side-effects. What's chilling is that those numbers only reflect what has been reported, the actual number of incidents may be much, much higher.

"Spot-On" products generally do not say in their advertising or marketing or even EPA mandated labeling that the products may cause death or other serious side-effects, including paralysis, seizures and ulcerated skin lesions. Consumers are largely unaware of these possibilities when applying the products to their dogs and cats.

Michael Green of Green & Associates, LLC, one of the attorneys that filed the New Jersey class actions, stated, "I've received a number of phone calls from pet owners in the middle of the night, where they are traumatized after their dog or cat has just died in their arms after they placed these pesticides on them. These are innocent pets who were trusting their owner to do the right thing for them. The owners are horrified to think that they gave their pet something that killed them, often in an excruciatingly painful way.  Most tragic are those stories where the owner had one pet die only to put it on another pet after being assured there was no connection to the product and have that pet die also. I've gotten a few of those calls too. Unfortunately, the law treats our dogs and cats as just chattel, but if you ask any of these pet owners whose pet died, their dog or cat was a member of their family." 

Sold By Major Retailers and Veterinarians

The "Spot-On" tick and flea business is estimated to be an $8 billion a year industry with the products primarily sold by veterinarians and pet store retailers such as PetCo and PetSmart. 

This week, PetArmor, a new "Spot-On" flea and tick product for dogs and cats, is being served with the complaint filed against it.  PetArmor was launched on April 20, 2011 in a press conference with the ASPCA.  The product has been featured in television ads and is sold in major retailer WalMart.  It is described by the manufacturer, FidoPharm, as containing the same active ingredients as Frontline, a well-known veterinarian recommended product.   

Other "Spot-On" products sued in the class actions in New Jersey, beginning in January 2010, include  Frontline, manufactured by Merial Limited, and those manufactured and sold by the other major animal pharmaceutical corporations Sergeant's Pet Care Products, Inc., Hartz Mountain Corporation, Bayer Healthcare, LLC, Farnum Companies, Wellmark International, Inc. and Summit VetPharm, LLC.  

"Spot-On" Flea and Tick products are now recommended for virtually all dogs and cats, no matter the locale or specific risk.  The Spot-On industry and vets who profit in the billions of dollars have not been called to account as to whether the risk vs. benefits really necessitate that common household pets across this country, and the children and other humans in these households, need to be exposed to these pesticides and neurotoxins 24/7.  Studies have shown that the pesticides are detectible on the hands  after petting.

EPA Complaints

Over 75,000 complaints to the EPA have been made since 2008 regarding these products including complaints of death and other serious side-effects even without a centralized poison reporting center, something the Humane Society is now calling for.  In April of 2009, the Environmental Protection Agency (EPA) issued an advisory and reported that there was a noticeable increase in the number of adverse pet reactions involving the "Spot-On" pesticides which act as neurotoxins. 

Nexus Between ASPCA and "Spot-On" Industry

FidoPharm enlisted the aid of the ASPCA in launching an awareness of their "Spot-On" product PetArmor.  However, the class action complaint alleges a nexus of relationships between executives of the "Spot-On" product manufacturers and the ASPCA, heretofore known to the public as a non-profit entity established to prevent cruelty to animals. 

The ASPCA has selected FidoPharm as its official tick and flea sponsor in its adoption centers and clinics.  FidoPharm in turn has donated product and $100,000 to the ASPCA. John Preston, the current chairman of FidoPharm's parent, was the founding executive of Merial, the maker of Frontline. 

Dr. Steven R. Hanson, the Senior Vice President and head of the ASPCA's Poison Control Center, where adverse reports of "Spot-On" products may be made, is a former director of Wellmark.  Hartz is a corporate donor to the ASPCA and named Dr. Hanson "Veterinarian of the Year."  The complaint alleges that calls into the Poison Control Center regarding Hartz "Spot-On" products are redirected to Hartz, allowing Hartz to directly manage any of these adverse events. 

In addition, the ASPCA has a for-profit arm, APCC Consulting Services, that provides professional services to animal pharmaceutical corporations, including consultation on product liability. Hartz has been a client of the APCC.  

Finally, the ASPCA in a press release, in response to the 2009 EPA advisory regarding "Spot-On" products, quoted Dr. Hanson as stating the products should continue to be used.

The plaintiffs of the class actions allege that the pesticides in the "Spot-On" products cause death, paralysis, seizures and skin lesions to their pets and that these adverse affects are not stated in the advertising or marketing to pet owners.

More information regarding the class action lawsuits filed against FidoPharm and others may be obtained at www.spotoncomplaints.com

Contact:  Michael S. Green, Esq., Green & Associates, LLC
Tel: 732-390-0480, Email: [email protected]

SOURCE Green & Associates, LLC

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.